BrainCool AB (publ) (STO:BRAIN)

Market Cap	276.41M -40.8%
Revenue (ttm)	38.69M -9.4%
Net Income	-37.05M
EPS	-0.15
Shares Out	394.88M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,768,404
Average Volume	1,211,676
Open	0.7090
Previous Close	0.7000
Day's Range	0.6400 - 0.7490
52-Week Range	0.4105 - 1.9200
Beta	1.28
RSI	69.76
Earnings Date	Feb 11, 2026

About BrainCool AB

BrainCool AB (publ), a medical device company, together with its subsidiaries, engages in the development, marketing, and sale of medical cooling systems for the healthcare sector in Sweden. The company offers BrainCool system, a system to monitor and control a patient’s temperature to anatomical zones for head/neck, thighs, and torso. It also offers RhinoChill system, a portable and battery-powered cooling product to spray liquid coolant for patient’s nostrils with a catheter; Cooral system provides medical professionals a way to reduce the ri...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2010
• Employees: 17
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BRAIN

Financial Performance

In 2025, BrainCool AB's revenue was 38.69 million, a decrease of -9.39% compared to the previous year's 42.69 million. Losses were -37.05 million, -15.88% less than in 2024.